En español
NIDA

Global Health

Naltrexone Implant Outperforms Daily Pill in Russian Trial

More than half of heroin-addicted patients treated with naltrexone via an implanted delivery device maintained abstinence throughout a 6-month clinical trial in Saint Petersburg, Russia. The implant device, which releases a steady dose of naltrexone continuously for 2 months, averted relapse to heroin use three times as effectively as daily oral doses of the medication.

Seek-Test-Treat-Retain To Stop the Spread of HIV

NIDA Director Nora Volkow

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

Linking NIDA to Researchers on a Global Scale

Highlights the NIDA International Program which works to strengthen international research networks, creating opportunities for global research collaboration, training, and scientific exchange.

United States Ranks First in Lifetime Use of Three Drugs

Highlights the disproportionately high rate of Americans who have used cocaine at some time during their lives as compared with other nations surveyed.

Study Gives Green Light to Antiretroviral Medications for HIV-Infected Injection Drug Users

Reports finding from a study showing that access to antiretroviral therapies, HAART in particular, can improve the health of HIV-infected patients who have a history of injection drug use.

Injection Drug Users Acquire Hepatitis C Infection Later in Developed Countries

Reports trends in onset of injection drug use to infection with hepatitis C virus in developed countries and notes the influence of prevention efforts.

James A. Inciardi (1939-2009)

Remembers Dr. James A. Inciardi, founder and co-director of the Center for Drug and Alcohol Studies and professor at the University of Delaware, who died on November 23, 2009.

Global Health

Brief Description

NIDA supports global research to find evidence-based solutions to the public health problems of drug abuse, addiction, and drug-related HIV/AIDS. We recognize that addiction knows no borders, and that no country can solve the problem by acting alone. Through our International Program, NIDA fosters international cooperative research and the exchange of scientific information between drug abuse researchers around the world.

Other Resources

Past information on many drugs of abuse is available on our Archives site.

Subscribe to Global Health